Unveiling Immunomodulatory Effects of Euglena gracilis in Immunosuppressed Mice: Transcriptome and Pathway Analysis
Journal of Microbiology and Biotechnology · 2024
DOI: 10.4014/jmb.2401.01006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Microbiology and Biotechnology, 2024. Verfasst von Seon Ha Jo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Science and Biotechnology, Seoul National University of Science and Technology, Seoul 01811, Republic of Korea. Hauptthemen laut MEDLINE: Euglena gracilis, Spleen, Gene Expression Profiling, Transcriptome. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ministry of Oceans and Fisheries.
Abstract (Originalsprache)
The immunomodulatory effects of Euglena gracilis (Euglena) and its bioactive component, β-1,3-glucan (paramylon), have been clarified through various studies. However, the detailed mechanisms of the immune regulation remain to be elucidated. This study was designed not only to investigate the immunomodulatory effects but also to determine the genetic mechanisms of Euglena and β-glucan in cyclophosphamide (CCP)-induced immunosuppressed mice. The animals were orally administered saline, Euglena (800 mg/kg B.W.) or β-glucan (400 mg/kg B.W.) for 19 days, and CCP (80 mg/kg B.W.) was subsequently administered to induce immunosuppression in the mice. The mice exhibited significant decreases in body weight, organ weight, and the spleen index. However, there were significant improvements in the spleen weight and the spleen index in CCP-induced mice after the oral administration of Euglena and β-glucan. Transcriptome analysis of the splenocytes revealed immune-related differentially expressed genes (DEGs) regulated in the Euglena- and β-glucantreated groups. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses indicated that pathways related with interleukin (IL)-17 and cAMP play significant roles in regulating T cells, B cells, and inflammatory cytokines. Additionally, Ptgs2, a major inflammatory factor, was exclusively expressed in the Euglena-treated group, suggesting that Euglena's beneficial components, such as carotenoids, could regulate these genes by influencing immune lymphocytes and inflammatory cytokines in CCP-induced mice. This study validated the immunomodulatory effects of Euglena and highlighted its underlying mechanisms, suggesting a positive contribution to the determination of phenotypes associated with immune-related diseases and the research and development of immunotherapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Food Science and Biotechnology, Seoul National University of Science and Technology, Seoul 01811, Republic of Korea.
- Department of Nano Bio Engineering, Seoul National University of Science and Technology, Seoul 01811, Republic of Korea.
Förderung
- Ministry of Oceans and Fisheries
Zitieren
APA
Jo, S. H., Jo, K. A., Park, S. Y., & Kim, J. Y. (2024). Unveiling Immunomodulatory Effects of Euglena gracilis in Immunosuppressed Mice: Transcriptome and Pathway Analysis. Journal of Microbiology and Biotechnology. https://doi.org/10.4014/jmb.2401.01006
Vancouver
Jo SH, Jo KA, Park SY, Kim JY. Unveiling Immunomodulatory Effects of Euglena gracilis in Immunosuppressed Mice: Transcriptome and Pathway Analysis. Journal of Microbiology and Biotechnology. 2024. doi:10.4014/jmb.2401.01006
BibTeX
@article{Jo2024,
author = {Jo, Seon Ha and Jo, Kyeong Ah and Park, Soo-Yeon and Kim, Ji Yeon},
title = {Unveiling Immunomodulatory Effects of Euglena gracilis in Immunosuppressed Mice: Transcriptome and Pathway Analysis},
journal = {Journal of Microbiology and Biotechnology},
year = {2024},
doi = {10.4014/jmb.2401.01006}
}
EUVIMED